These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 29989261)

  • 1. Women prefer proactive support from providers for treatment of heavy menstrual bleeding: A qualitative study in adult women with moderate or severe Von Willebrand disease.
    Eising HP; Sanders YV; de Meris J; Leebeek FWG; Meijer K
    Haemophilia; 2018 Nov; 24(6):950-956. PubMed ID: 29989261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An approach to outreach patients with von Willebrand disease in Egypt by targeting women with heavy menstrual bleeding and/or bleeding symptoms.
    Sherif N; Goubran H; Hassan A; Burnouf T; El-Ekiaby M
    Haemophilia; 2014 Mar; 20(2):238-43. PubMed ID: 24251732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic and therapeutic strategies for intraoperative bleeding in women with von Willebrand disease and heavy menstrual bleeding: A systematic review.
    Eising HP; Punt MC; Leemans JC; Bongers MY
    Blood Rev; 2023 Nov; 62():101131. PubMed ID: 37716881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. von Willebrand disease and bleeding in women.
    Ragni MV; Bontempo FA; Hassett AC
    Haemophilia; 1999 Sep; 5(5):313-7. PubMed ID: 10583512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial.
    Ragni MV; Rothenberger SD; Feldman R; Nance D; Leavitt AD; Malec L; Kulkarni R; Sidonio R; Kraut E; Lasky J; Pruthi R; Angelini D; Philipp C; Hwang N; Wheeler AP; Seaman C; Machin N; Xavier F; Meyer M; Bellissimo D; Humphreys G; Smith KJ; Merricks EP; Nichols TC; Ivanco D; Vehec D; Koerbel G; Althouse AD
    Lancet Haematol; 2023 Aug; 10(8):e612-e623. PubMed ID: 37385272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gynaecological and obstetric bleeding in moderate and severe von Willebrand disease.
    De Wee EM; Knol HM; Mauser-Bunschoten EP; van der Bom JG; Eikenboom JC; Fijnvandraat K; De Goede-Bolder A; Laros-van Gorkom B; Ypma PF; Zweegman S; Meijer K; Leebeek FW;
    Thromb Haemost; 2011 Nov; 106(5):885-92. PubMed ID: 21947221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated von Willebrand factor levels during heavy menstrual bleeding episodes limit the diagnostic utility for von Willebrand disease.
    Brown MC; White MH; Friedberg R; Woods K; Childress K; Kulkarni M; Sidonio RF
    Res Pract Thromb Haemost; 2021 May; 5(4):e12513. PubMed ID: 33977212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of bleeding phenotype in adult patients with moderate or severe von Willebrand disease.
    de Wee EM; Sanders YV; Mauser-Bunschoten EP; van der Bom JG; Degenaar-Dujardin ME; Eikenboom J; de Goede-Bolder A; Laros-van Gorkom BA; Meijer K; Hamulyák K; Nijziel MR; Fijnvandraat K; Leebeek FW;
    Thromb Haemost; 2012 Oct; 108(4):683-92. PubMed ID: 22918553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of von Willebrand disease in women with iron deficiency anaemia and menorrhagia in Taiwan.
    Chen YC; Chao TY; Cheng SN; Hu SH; Liu JY
    Haemophilia; 2008 Jul; 14(4):768-74. PubMed ID: 18498402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in bleeding patterns in von Willebrand disease after institution of long-term replacement therapy: results from the von Willebrand Disease Prophylaxis Network.
    Holm E; Abshire TC; Bowen J; Álvarez MT; Bolton-Maggs P; Carcao M; Federici AB; Gill JC; Halimeh S; Kempton C; Key NS; Kouides P; Lail A; Landorph A; Leebeek F; Makris M; Mannucci P; Mauser-Bunschoten EP; Nugent D; Valentino LA; Winikoff R; Berntorp E
    Blood Coagul Fibrinolysis; 2015 Jun; 26(4):383-8. PubMed ID: 25688461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Von Willebrand factor for menorrhagia: a survey and literature review.
    Ragni MV; Machin N; Malec LM; James AH; Kessler CM; Konkle BA; Kouides PA; Neff AT; Philipp CS; Brambilla DJ
    Haemophilia; 2016 May; 22(3):397-402. PubMed ID: 26843404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of von Willebrand Disease on Women's Health Outcomes: A Matched Cohort Database Study.
    Hagberg KW; Jick S; Du P; Truong Berthoz F; Özen G; Tzivelekis S
    J Womens Health (Larchmt); 2022 Sep; 31(9):1262-1270. PubMed ID: 35960825
    [No Abstract]   [Full Text] [Related]  

  • 13. Complications of hysterectomy in women with von Willebrand disease.
    James AH; Myers ER; Cook C; Pietrobon R
    Haemophilia; 2009 Jul; 15(4):926-31. PubMed ID: 19473420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant gynecological bleeding in women with low von Willebrand factor levels.
    Lavin M; Aguila S; Dalton N; Nolan M; Byrne M; Ryan K; White B; O'Connell NM; O'Sullivan JM; Di Paola J; James PD; O'Donnell JS
    Blood Adv; 2018 Jul; 2(14):1784-1791. PubMed ID: 30042144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrial ablation for von Willebrand disease-related menorrhagia--experience with seven cases.
    Rubin G; Wortman M; Kouides PA
    Haemophilia; 2004 Sep; 10(5):477-82. PubMed ID: 15357774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Von Willebrand Disease-Specific Aspects in Women.
    Eladly F; Miesbach W
    Hamostaseologie; 2022 Oct; 42(5):330-336. PubMed ID: 36323280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Menorrhagia and bleeding disorders in adolescent females.
    Halimeh S
    Hamostaseologie; 2012; 32(1):45-50. PubMed ID: 22127528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bleeding spectrum in children with moderate or severe von Willebrand disease: Relevance of pediatric-specific bleeding.
    Sanders YV; Fijnvandraat K; Boender J; Mauser-Bunschoten EP; van der Bom JG; de Meris J; Smiers FJ; Granzen B; Brons P; Tamminga RY; Cnossen MH; Leebeek FW;
    Am J Hematol; 2015 Dec; 90(12):1142-8. PubMed ID: 26375306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma levels of plasminogen activator inhibitor-1 and bleeding phenotype in patients with von Willebrand disease.
    Abdul S; Boender J; Malfliet JJMC; Eikenboom J; Fijn van Draat K; Mauser-Bunschoten EP; Meijer K; de Meris J; Laros-van Gorkom BAP; van der Bom JG; Leebeek FWG; Rijken DC; Uitte de Willige S;
    Haemophilia; 2017 May; 23(3):437-443. PubMed ID: 28306198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Von Willebrand disease.
    James AH
    Obstet Gynecol Surv; 2006 Feb; 61(2):136-45. PubMed ID: 16433937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.